Researchers report that all nine patients who were successfully treated for ADA-SCID in a UCLA clinical trial from 2009 to 2012 are still disease-free.
“We need to figure out how this is happening in order to develop treatments to stop it,” said UCLA’s Arjun Deb.
The five-year award from California’s stem cell agency will help prepare young scientists and physicians to become leaders in the regenerative medicine field.
A UCLA study suggests researchers could analyze neurological disorders in a stem cell–derived model.
The renowned neurologist and stem cell biologist is currently a professor at Stanford University.
UCLA researchers discover that MAOIs could activate immune system to shrink various types of tumors.
The treatment, developed by researchers from UCLA and the U.K., has restored immune function in more than 95% of patients in three clinical trials.
A UCLA study identifies a cell therapy that can stop progressive damage and stimulate the brain’s repair processes in mice.
Research brief: A UCLA team has demonstrated that altering a key molecule used in the therapy yields superior and longer-lasting results in mouse models.
The project is the first to use the Nobel prize–winning technology to directly correct sickle mutation in blood stem cells.
Professors Robert Damoiseaux and Vaithilingaraja Arumugaswami led a collaboration among scientists from the U.S. and Germany.
The advance could be a step toward the development of treatments for muscle loss or damage due to injury, age or disease.
UCLA’s Dr. Arjun Deb said the same model could also help researchers learn more about other similar viruses that might emerge in the future.
“It’s too early to declare victory, but it’s looking quite promising at this point,” said UCLA’s Dr. Donald Kohn.
Researchers used a model of airway tissue created from human stem cells to understand the process on cellular level.
The advance will enable scientists to follow the precise path by which T cells are formed from blood stem cells inside the thymus.
UCLA testing found that AMBMP allowed mouse muscles to work and grow the way healthy muscle cells do.
Broad Stem Cell Research Center investigators are are channeling their specialized expertise to fight the novel coronavirus.
A UCLA study sheds light on how aging can cause lung regeneration to go awry, which can lead to lung cancer and other diseases.
Two members of the UCLA Broad Stem Cell Research Center have received a grant for work that could be helpful in developing a vaccine.
Researchers will focus on an immunotherapy known as CAR T, which uses genetically modified stem cells to target and destroy the virus.
The findings are critical for researchers aiming to develop muscle stem cells in the lab that can be used to combat disease.
The findings could eventually lead to new drugs to treat or prevent lung cancer.
UCLA-led research uncovers new details about the Foxp1 gene, which also is involved in timing of neuron production.
UCLA researchers were part of an international team to test gene therapy in people with X-linked chronic granulomatous disease.